Lixte Biotech Hlds (LIXT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2022 | 03-2022 | 12-2021 | 09-2021 | 06-2021 | |
| Operating Expenses | 1,546 | 1,654 | 2,025 | 1,238 | 1,733 |
| Operating Income | -1,546 | -1,654 | -2,025 | -1,238 | -1,733 |
| Interest Expense | 1 | 3 | 5 | 0 | 1 |
| Other Income | 0 | 0 | 0 | -1 | 0 |
| Pre-tax Income | -1,546 | -1,657 | -2,029 | -1,239 | -1,733 |
| Net Income Continuous | -1,546 | -1,657 | -2,029 | -1,239 | -1,733 |
| Net Income | $-1,546 | $-1,657 | $-2,029 | $-1,239 | $-1,733 |
| EPS Basic Total Ops | -0.95 | -1.20 | -1.40 | -0.90 | -1.30 |
| EPS Basic Continuous Ops | -0.95 | -1.21 | -1.47 | -0.90 | -1.27 |
| EPS Diluted Total Ops | -0.95 | -1.20 | -1.40 | -0.90 | -1.30 |
| EPS Diluted Continuous Ops | -0.95 | -1.21 | -1.47 | -0.90 | -1.27 |
| EBITDA(a) | $-1,546 | $-1,654 | $-2,025 | $-1,238 | $-1,733 |